Search results

• HKU COVID-19 research named landmark paper in 200 years by The Lancet - A milestone signifying HKU’s contributions in the Greater Bay Area to achieve global impact

  Yuen, K. Y.

  7/2/23

  1 item of Media coverage

  Press/Media: Research

• HKU COVID-19 Research Named Landmark Paper In 200 Years By The Lancet - A Milestone Signifying HKU's Contributions In The Greater Bay Area To Achieve Global Impact

  Yuen, K. Y.

  6/2/23

  1 item of Media coverage

  Press/Media: Research

• HKU Achieves 13th Global Position With Record 50 Academics on Clarivate's Highly Cited Researchers 2023 List

  Yuen, K. Y.

  16/11/23

  1 item of Media coverage

  Press/Media: Research

• HKU Achieves 13th Global Position with Record 50 Academics on Clarivate's Highly Cited Researchers 2023 List

  Yuen, K. Y.

  3/12/23

  1 item of Media coverage

  Press/Media: Research

• HKU Achieves 13th Global Position with Record 50 Academics on Clarivate's Highly Cited Researchers 2023 List

  Yuen, K. Y.

  17/11/23

  1 item of Media coverage

  Press/Media: Research

• HK top microbiologist suggests universal antiviral drugs to prevent future pandemic

  Yuen, K. Y.

  5/4/23

  1 item of Media coverage

  Press/Media: Research

• HK sees 228 new cases, probe into hotel virus spread continues

  Yuen, K. Y.

  21/5/22

  1 item of Media coverage

  Press/Media: Research

• HK sees 228 new cases, probe into hotel virus spread continues

  Yuen, K. Y.

  21/5/22

  1 item of Media coverage

  Press/Media: Research

• HK man's Covid 'reinfection' raises concerns over immunity

  Yuen, K. Y.

  24/8/20

  1 item of Media coverage

  Press/Media: Research

• HK confirms first re-infection of coronavirus in IT worker

  Yuen, K. Y.

  25/8/20

  2 items of Media coverage

  Press/Media: Research

• HK at tipping point of Omicron outbreak, health chief says

  Yuen, K. Y.

  2/1/22

  1 item of Media coverage

  Press/Media: Research

• HK: Some practical masterpieces of scientific research works

  Yuen, K. Y.

  19/4/21

  1 item of Media coverage

  Press/Media: Research

• groups call for clear details on impact of project

  Yuen, K. Y.

  7/2/23

  1 item of Media coverage

  Press/Media: Research

• Gemilang International : (1) CHANGE OF DIRECTORS; (2) CHANGE IN COMPOSITION OF BOARD COMMITTEES; AND (3) CHANGE OF AUTHORISED REPRESENTATIVE

  Yuen, K. Y.

  1/4/21

  2 items of Media coverage

  Press/Media: Research

• Future Forum Announced the Winners of 2021 Future Science Prize: Kwok-Yung Yuen, Joseph Sriyal Malik Peiris, Jie Zhang, Simon Sze

  Yuen, K. Y.

  13/9/21

  12 items of Media coverage

  Press/Media: Research

• Fully Vaccinated Individuals at Risk for COVID Infection With Omicron Variant – Columbia Study

  Yuen, K. Y.

  24/12/21

  3 items of Media coverage

  Press/Media: Research

• Fully vaccinated individuals at risk for COVID infection with Omicron variant – Columbia Study

  Yuen, K. Y.

  25/12/21

  1 item of Media coverage

  Press/Media: Research

• Focus on Cutting-Edge Exploration and Share a Feast of Science

  Yuen, K. Y.

  1/12/21

  1 item of Media coverage

  Press/Media: Research

• Focus on Cutting-Edge Exploration and Share a Feast of Science

  Yuen, K. Y.

  1/12/21

  11 items of Media coverage

  Press/Media: Research

• Five HKU Scholars Top Asia Rankings in Their Fields: Research.com

  Yuen, K. Y.

  18/6/24

  1 item of Media coverage

  Press/Media: Research

• Five HKU Scholars Ranked First in Asia in Respective Disciplines by Research.com

  Yuen, K. Y.

  19/6/24

  1 item of Media coverage

  Press/Media: Research

• First documented case of coronavirus reinfection confirmed in Hong Kong

  Yuen, K. Y.

  25/8/20

  1 item of Media coverage

  Press/Media: Research

• FIRST COVID-19 REINFECTION CASE CONFIRMED IN HONG KONG

  Yuen, K. Y.

  25/8/20

  1 item of Media coverage

  Press/Media: Research

• First Case of COVID-19 Reinfection Confirmed

  Yuen, K. Y.

  24/8/20

  1 item of Media coverage

  Press/Media: Research

• Findings on COVID-19 Discussed by Investigators at University of North Carolina Chapel Hill (Engineering a "muco-trapping" Ace2-immunoglobulin Hybrid With Picomolar Affinity As an Inhaled, Pan-variant Immunotherapy for Covid-19)

  Yuen, K. Y.

  4/3/24

  1 item of Media coverage

  Press/Media: Research